Showing results (911-920 of 1,194) with videos related to

Sort By:
Pageof 120
Scientific Reports|May 11, 2016
Recurrent hormone-binding domain truncated ESR1 amplifications in primary endometrial cancers suggest their implication in hormone independent growthFrederik Holst, Erling A Hoivik, William J Gibson, et al.
Cell|February 5, 2019
Commensal Microbiota Promote Lung Cancer Development via γδ T CellsChengcheng Jin, Georgia K Lagoudas, Chen Zhao, et al.
Schizophrenia Research|May 29, 2009
Smaller superior temporal gyrus volume specificity in schizotypal personality disorderKim E Goldstein, Erin A Hazlett, Antonia S New, et al.
Bioinformatics (Oxford, England)|August 30, 2022
Tangent normalization for somatic copy-number inference in cancer genome analysisGalen F Gao, Coyin Oh, Gordon Saksena, et al.
Cancer Discovery|June 5, 2014
EGFR variant heterogeneity in glioblastoma resolved through single-nucleus sequencingJoshua M Francis, Cheng-Zhong Zhang, Cecile L Maire, et al.
Cold Spring Harbor Molecular Case Studies|May 6, 2016
Complete hematologic response of early T-cell progenitor acute lymphoblastic leukemia to the γ-secretase inhibitor BMS-906024: genetic and epigenetic findings in an outlier caseBirgit Knoechel, Ami Bhatt, Li Pan, et al.
Aob PLANTS|January 1, 2017
Evolutionary dynamics of tree invasions: complementing the unified framework for biological invasionsRafael Dudeque Zenni, Ian A Dickie, Michael J Wingfield, et al.
Gut|April 1, 2021
Pan-ERBB kinase inhibition augments CDK4/6 inhibitor efficacy in oesophageal squamous cell carcinomaJin Zhou, Zhong Wu, Zhouwei Zhang, et al.
Neuron|May 27, 2003
Cdk5 is a key factor in tau aggregation and tangle formation in vivoWendy Noble, Vicki Olm, Kazuyuki Takata, et al.
Neuro-Oncology|January 25, 2023
Telomerase inhibition is an effective therapeutic strategy in TERT promoter-mutant glioblastoma models with low tumor volumeElisa Aquilanti, Lauren Kageler, Jacqueline Watson, et al.
Pageof 120